LPL Financial LLC Purchases 244 Shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

LPL Financial LLC raised its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 0.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,139 shares of the company’s stock after acquiring an additional 244 shares during the period. LPL Financial LLC owned approximately 1.66% of Invesco Pharmaceuticals ETF worth $4,256,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of PJP. Bank of America Corp DE grew its holdings in shares of Invesco Pharmaceuticals ETF by 5.4% in the fourth quarter. Bank of America Corp DE now owns 45,825 shares of the company’s stock worth $3,786,000 after purchasing an additional 2,336 shares during the last quarter. Focus Partners Wealth bought a new position in shares of Invesco Pharmaceuticals ETF in the fourth quarter worth about $488,000. Bank of Montreal Can grew its holdings in shares of Invesco Pharmaceuticals ETF by 48.7% in the fourth quarter. Bank of Montreal Can now owns 1,044 shares of the company’s stock worth $86,000 after purchasing an additional 342 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Invesco Pharmaceuticals ETF by 8.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,364 shares of the company’s stock worth $691,000 after purchasing an additional 635 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Invesco Pharmaceuticals ETF by 6.3% in the fourth quarter. JPMorgan Chase & Co. now owns 4,301 shares of the company’s stock worth $355,000 after purchasing an additional 255 shares during the last quarter.

Invesco Pharmaceuticals ETF Trading Up 0.2%

NYSEARCA PJP opened at $89.46 on Friday. The company’s 50-day moving average price is $82.56 and its 200-day moving average price is $82.44. The stock has a market cap of $256.75 million, a PE ratio of 15.59 and a beta of 0.66. Invesco Pharmaceuticals ETF has a 12 month low of $72.25 and a 12 month high of $89.87.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.